Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers

Journal of Lipid Research

Volumn 47, Issue 1, 2006, Pages 42-50

  Bergheim, Ina ^a   Harsch, Simone ^a   Mueller, Oliver ^b   Schimmel, Silke ^a   Fritz, Peter ^b   Stange, Eduard F ^b  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Gallstone; Intestine; Nuclear receptor

Indexed keywords

FARNESOID X RECEPTOR; LIPID BINDING PROTEIN; MEMBRANE PROTEIN; NUCLEAR FACTOR I; SODIUM BILE ACID TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE ACID SYNTHESIS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GALLBLADDER BIOPSY; GALLBLADDER EPITHELIUM; GALLBLADDER MUCOSA; GALLSTONE; HETEROZYGOTE; HUMAN; MALE; PATIENT CODING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STONE FORMATION;

AGED; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; FEMALE; GALLSTONES; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; ILEUM; INTESTINAL MUCOSA; MIDDLE AGED; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SYMPORTERS; TRANSCRIPTION FACTORS;

EID: 30844471761     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500215-JLR200     Document Type: Article

References (44)

1. Dowling, R. H. 2000. Review. Pathogenesis of gallstones. Aliment. Pharmacol. Ther. 2: 39-47.
2. LaMont, J. T., and M. C. Carey. 1992. Cholesterol gallstone formation. II. Pathobiology and pathomechanics. Prog. Liver Dis. 10: 165-191.
3. Fuchs, M., B. Ivandic, O. Muller, C. Schalla, J. Scheibner, P. Bartsch, and E. F. Stange. 2001. Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic upregulation of the high-density lipoprotein receptor SRBI. Hepatology. 33: 1451-1459.
4. Empen, K., K. Lange, E. F. Stange, and J. Scheibner. 1997. Newly synthesized cholesterol in human bile and plasma: quantification by mass isotopomer distribution analysis. Am. J. Physiol. 272: G367-G373.
5. Shoda, J., B. F. He, N. Tanaka, Y. Matsuzaki, T. Osuga, S. Yamamori, H. Miyazaki, and J. Sjovall. 1995. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology. 21: 1291-1302.
6. Brand, B., L. Lerche, and E. F. Stange. 2002. Symptomatic or asymptomatic gallstone disease: is the gallbladder motility the clue? Hepatogastroenterology. 49: 1208-1212.
7. Berr, F., E. Pratschke, S. Fischer, and G. Paumgartner. 1992. Disorders of bile acid metabolism in cholesterol gallstone disease. J. Clin. Invest. 90: 859-868.
8. Morris, J. S., T. S. Low-Beer, and K. W. Heaton. 1973. Bile salt metabolism and the colon. Scand. J. Gastroenterol. 8: 425-431.
9. Shneider, B. L. 2001. Intestinal bile acid transport: biology, physiology, and pathophysiology. J. Pediatr. Gastroenterol. Nutr. 32: 407-417.
10. Wong, M. H., P. Oelkers, A. L. Craddock, and P. A. Dawson. 1994. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J. Biol. Chem. 269: 1340-1347.
11. Heubi, J. E., W. F. Balistreri, J. D. Fondacaro, J. C. Partin, and W. K. Schubert. 1982. Primary bile acid malabsorption: defective in vitro ileal active bile acid transport. Gastroenterology. 83: 804-811.
12. Wong, M. H., P. Oelkers, and P. A. Dawson. 1995. Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity. J. Biol. Chem. 270: 27228-27234.
13. Tougaard, L., B. Giese, B. H. Pedersen, and V. Binder. 1986. Bile acid metabolism in patients with Crohn's disease in terminal ileum. Scand. J. Gastroenterol. 21: 627-633.
14. Heuman, R., R. Sjodahl, P. Tobiasson, and C. Tagesson. 1982. Postprandial serum bile acids in resected and non-resected patients with Crohn's disease. Scand. J. Gastroenterol. 17: 137-140.
15. 75Se)-labelled bile acid for the investigation of terminal ileal function. Hepatogastroenterology. 31: 187-191.
16. Kramer, W., F. Girbig, U. Gutjahr, S. Kowalewski, K. Jouvenal, G. Müller, D. Tripier, and G. Wess. 1993. Intestinal bile acid absorption. J. Biol. Chem. 268: 18035-18046.
17. Gong, Y. Z., E. T. Everett, D. A. Schwartz, J. S. Norris, and F. A. Wilson. 1994. Molecular cloning, tissue distribution, and expression of a 14-kDa bile acid-binding protein from rat ileal cytosol. Proc. Natl. Acad. Sci. USA. 91: 4741-4745.
18. Lazaridis, K. N., L. Pham, P. Tietz, R. A. Marinelli, P. C. deGroen, S. Levine, P. A. Dawson, and N. F. LaRusso. 1997. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodiumdependent bile acid transporter. J. Clin. Invest. 100: 2714-2721.
19. 3). J. Biol. Chem. 275: 2905-2910.
20. Dawson, P. A., M. Hubbert, J. Haywood, A. L. Craddock, N. Zerangue, W. V. Christian, and N. Ballatori. 2005. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J. Biol. Chem. 280: 6960-6968.
21. Shih, D. Q., M. Bussen, E. Sehayek, M. Ananthanarayanan, B. L. Shneider, F. J. Suchy, S. Shefer, J. S. Bollileni, F. J. Gonzalez, J. L. Breslow, et al. 2001. Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat. Genet. 27: 375-382.
22. Jung, D., M. Fried, and G. A. Kullak-Ublick. 2002. Human apical sodium-dependent bile salt transporter (SLC10A2) gene is regulated by the peroxisome proliferator-activated receptor alpha 4. J. Biol. Chem. 277: 30559-30566.
23. Schwarz, M., D. W. Russell, J. M. Dietschy, and S. D. Turley. 1998. Marked reduction in bile acid synthesis in cholesterol 7alphahydroxylase- deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J. Lipid Res. 39: 1833-1843.
24. Grober, J., I. Zaghini, H. Fujii, S. A. Jones, S. A. Kliewer, T. M. Willson, T. Ono, and P. Besnard. 1999. Identification of a bile acidresponsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J. Biol. Chem. 274: 29749-29754.
25. Zaghini, I., J. F. Landrier, J. Grober, S. Krief, S. A. Jones, M. C. Monnot, I. Lefrere, M. A. Watson, J. L. Collins, H. Fujii, et al. 2002. Sterol regulatory element-binding protein-1c is responsible for cholesterol regulation of ileal bile acid-binding protein gene in vivo. Possible involvement of liver-X-receptor. J. Biol. Chem. 277: 1324-1331.
26. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
27. Mamianetti, A., D. Garrido, C. N. Carducci, and M. C. Vescina. 1999. Fecal bile acid excretion profile in gallstone patients. Medicina (B. Aires). 59: 269-273.
28. Wells, J. E., F. Berr, L. A. Thomas, R. H. Dowling, and P.B. Hylemon. 2000. Isolation and characterization of cholic acid 7alpha-dehydroxylating fecal bacteria from cholesterol gallstone patients. J. Hepatol. 32: 4-10.
29. Berr, F., G. A. Kullak-Ublick, G. Paumgartner, W. Munzing, and P. B. Hylemon. 1996. 7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology. 111: 1611-1620.
30. Thomas, L. A., M. J. Veysey, T. Bathgate, A. King, G. French, N. C. Smeeton, G. M. Murphy, and R. H. Dowling. 2000. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology. 119: 806-815.
31. Vlahcevic, Z. R., C. C. Bell, I. Buhac, J. T. Farrar, and L. Swell. 1970. Diminished bile acid pool size in patients with gallstones. Gastroenterology. 59: 165-173.
32. Nilsell, K., B. Angelin, L. Liljeqvist, and K. Einarsson. 1985. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Gastroenterology. 89: 287-293.
33. Muhrbeck, O., F. H. Wang, I. Bjorkhem, M. Axelson, and K. Einarsson. 1997. Circulating markers for biosynthesis of cholesterol and bile acids are not depressed in asymptomatic gallstone subjects. J. Hepatol. 27: 150-155.
34. Stange, E. F., J. Scheibner, and H. Ditschuneit. 1989. Role of primary and secondary bile acids as feedback inhibitors of bile acid synthesis in the rat in vivo. J. Clin. Invest. 84: 173-180.
35. Heuman, D. M., P. B. Hylemon, and Z. R. Vlahcevic. 1989. Regulation of bile acid synthesis. III. Correlation between biliary bile salt hydrophobicity index and the activities of enzymes regulating cholesterol and bile acid synthesis in the rat. J. Lipid Res. 30: 1161-1171.
36. Pandak, W. M., Z. R. Vlahcevic, D. M. Heuman, K. S. Redford, J. Y. Chiang, and P. B. Hylemon. 1994. Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7 alpha-hydroxylase. Hepatology. 19: 941-947.
37. Tauber, G., K. Empen, J. Scheibner, M. Fuchs, and E. F. Stange. 1996. Feedback regulation of bile acid synthesis measured by stable isotope kinetics in humans. Eur. J. Gastroenterol. Hepatol. 8: 23-31.
38. Hillebrant, C., B. Nyberg, B. Angelin, M. Axelson, I. Bjorkhem, M. Rudling, and C. Einarsson. 1999. Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7alpha-hydroxylase activity. J. Intern. Med. 246: 399-407.
39. Mabee, T. M., P. Meyer, L. Den Besten, and E. E. Mason. 1976. The mechanism of increased gallstone formation in obese human subjects. Surgery. 79: 460-468.
40. Chen, F., L. Ma, R. B. Sartor, F. Li, H. Xiong, A. Q. Sun, and B. Shneider. 2002. Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation. Gastroenterology. 123: 2005-2016.
41. Neimark, E., F. Chen, X. Li, and B. L. Shneider. 2004. Bile acidinduced negative feedback regulation of the human ileal bile acid transporter. Hepatology. 40: 149-156.
42. Hruz, P., C. Zimmermann, H. Gutmann, L. Degen, U. Beuers, L. Terracciano, J. Drewe, and C. Beglinger. 2005. Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis. Gut. In press.
43. Sinal, C. J., M. Tohkin, M. Miyata, J. M. Ward, G. Lambert, and F. J. Gonzalez. 2000. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell. 102: 731-744.
44. Moschetta, A., A. L. Bookout, and D. J. Mangelsdorf. 2004. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat. Med. 10: 1352-1358.